ventilated. In 7 patients, death occurred before they reached the ICU and they were not included in our study.
Surveillance of SE
For each SE episode vital parameters and total number of generalized tonic-clonic (GTC) seizures were observed, as well as the duration of SE, and time from the application of effective antiepileptic drug (AED) to the SE severance.
Therapeutic protocol
Patients were treated according to the standardized hospitalwide therapeutic protocol. However, during the 10-year period the protocol was occasionally violated mainly due to a periodic lack of particular AED on local market.
Definition of SE
SE is defined as ''a condition in which epileptic activity persists for 30 min or longer, causing a wide spectrum of clinical symptoms'', 2 and short-term mortality as death during the first 30 days following episode of SE. 10 SE cessation was clinically defined as a complete abolition of convulsions with normalization of autonomic parameters for GTC and partial motor (PM) SE, and abolishing of abnormal stereotype behavior with regaining of consciousness for non-convulsive SE. For all patients with nonconvulsive SE and majority of patients remaining in coma for at least 4 h, EEG confirmed SE severance as soon as possible during regular working hours.
Classification of SE
In collaboration with the attending physician one of us (D.V.S.) classified SE according to clinical and, if available, EEG criteria.
Criteria for etiology of death
The etiology of death was determined for each patient. In each case of death, two types of etiologies and their combinations were determined: (1) severe underlying disease, and (2) complications caused by convulsions, therapy, and/or coma with no signs of severe underlying disease. Criteria for differentiation between etiologies depended on clinical assessment of the sequence of events that led to death in each particular case. If several etiologies contributed to death, their combination was considered as the principal cause. If complication of the severe underlying disease contributed to death, it was regarded as the most important, because neither SE nor other complications would have appeared in absence of the underlying disease.
Diagnosis of underlying disease
Diagnosis of underlying disease was made by the integration of clinical data and the results of complementary examination. Available anamnestic data were collected, and detailed physical, neurological examinations and CT scans were performed on all patients. Brain MRI was performed on approximately 1 among 3 patients according to availability at the time of study. ECG, EEG, blood biochemistry, complete blood count and chest X-ray, CSF examination, VDRL, various serological, toxicological, and bacteriological and virusological (mainly antibody titers for Herpes simplex I and II viruses, and HIV) tests were used frequently. Other tests were performed when that was justified. In majority of deceased patients, clinical presentation of underlying diseases was obvious and fulfilled the criteria for the diagnosis of particular type of disease. According to prevalent prognosis, different etiologies were classified as severe (that could lead to death) or benign (that usually do not lead to death).
Definition of complications caused by convulsions
Complications of vigorous convulsions resulted from powerful and protracted muscle contractions and comprised tongue bite, rhabdomyolysis, physical injuries, and RD.
Definition of complications caused by therapy
Antistatus therapy complications were related to intravenous application of the AED. RD, apnea, and cardiac arrest were complications caused by therapy only in cases when they occurred immediately (approximately within 10 min) following intravenous application of the antistatus drug. Criteria for RD were decrease of ventilator effort, cyanosis and direct demonstration of the increase of pCO 2 and decrease of pO 2 in arterial blood. Apnea was diagnosed as severance of breathing with no tendency for spontaneous recovery during at least 30 s.
Definition of complications caused by coma
Coma was the consequence of the underlying disease, prolonged convulsions, or late complication of antistatus therapy. Regarding the fact that coma causes complications not because of its etiology, but only because of its duration, it was recognized as the independent morbogenic factor. Complications that were caused by coma were consequence of prolonged immobility and included bedsores, infections, venous thromboses and embolism, or corneal perforation. The longer the duration of coma the more serious were the complications. Although coma complications were among the most serious, majority were preventable or curable.
Statistical tests
The following statistical tests were used in: Chi square test; Mann-Whitney's test; signed rank sum test; Friedman's test; Kruskal-Wallis' test; non-parametric Spearman's correlation, Student's t test; analysis of variance; and normal and binomial distribution test.
Results

Whole population
During a 10-year period, there were 920 SE episodes among 750 patients. Two patients had more than 10 SE episodes, 9 had 5-9, 24 had 3-4, 42 had 2 and 673 (73.1%) patients had a single SE episode. In case of 873 (94.9%) episodes, SE started before the admission to hospital and in 47 (5.1%) cases after the admission. Six hundred and two (65.4%) episodes were intercurrent and 318 (34.6%) were initial. SE was classified as GTC (725, 78.8%), PM (98, 10.7%), nonconvulsive (93, 10%) or myoclonic (4 patients, 0.5%). EEG was performed in 102 (11%) episodes during and in 761 (82.7%) after the termination of SE. Among patients who died (120 of them) EEG was performed with 73 patients (60.1%).
Treatment of SE
Majority of patients (60.6%) were treated with more than one AED. Initial AEDs were intravenous diazepam (591) and midazolam (310), followed by intravenous phenobarbital (174), and phenytoin (166 patients). AEDs which influenced SE finally to stop were diazepam (351), midazolam (228), phenobarbital (149), phenytoin (86), thiopental (23) , and other (27 patients). SE terminated spontaneously in case of 12 patients, and after intramuscular application of less than 10 mg of diazepam or less than 15 mg of midazolam in case of 30 patients. Twelve patients died because SE could not be aborted by antiepileptic drug therapy.
Patients who died
During the period of 10 years, 120 (13%) patients with SE died. In majority of cases diagnosis was established on the basis of clinical presentation and antemortem examinations. Average age of deceased patients with SE was significantly higher compared to those who survived (53 AE 15.5 and 40.3 AE 15.4 years, respectively; p = 0.0001). Among those who died, GTC SE (83.3% vs. 78.1%), PM SE (13.4% vs. 10.2%) and myoclonic SE (0.8% vs. 0.4%), were more frequent while non-convulsive SE (2.5% vs. 11.3%) was less frequent compared with patients who survived (p = 0.015). Duration of SE was significantly longer (p = 0.0001) with patients who died (median: 4.3 h; range: 0.5-936) compared to those who survived (median: 3.1 h; range: 0.5-1128). Mortality was 4% among 90 patients with SE lasting less than one hour, and 24% among 29 patients with SE lasting more than 24 h (p = 0.033). Positive correlation was found between the duration of SE and mortality: the longer duration the higher mortality, with no critical duration after which mortality was not increased (p = 0.001, r = +0.117). Average number of GTC seizures and response to AEDs were not significantly different among patients who did and patients who did not die (p = 0.075-0.823). Table 1 shows the etiology of death. Death was due to serious underlying (or co-morbid) disease in 79 cases (65.8%) and to the combination of serious underlying disease and other etiologies in 27 (22.5%) cases (Table 1 ). In case of 27 patients with multiple etiologies of death, ''severe'' etiology was the most important factor. However, the patients' condition significantly deteriorated due to development of apnea or RD after therapy (9), emergence of bacterial infections (sepsis or pneumonia) due to prolonged coma (8) or combination of more than two factors (10 patients). The duration of postictal coma was significantly longer with patients who died due to serious underlying disease compared with patients who did not die (159.3 AE 239.6 and 12.2 AE 48.8 h, respectively; p = 0.0001). Table 2 shows the list of serious underlying diseases that caused death in our patients.
Etiology of death
Among the remaining 14 patients (11.7%), death was not caused by underlying disease but by convulsions, therapy and coma (4), therapy (3), therapy and coma (3), coma (2) and convulsions and coma (2 patients) ( Table 1) . In those patients, there was no serious etiology or co-morbidity that could explain death. Actually, SE was caused by AED withdrawal in 4, and cryptogenic etiology in 10 patients, while etiology of previous chronic epilepsy was cryptogenic in 9 and chronic non-progressive symptomatic in 5 patients.
In 11 out of 14 patients, prolonged coma (range: 4-1152; median: 300 h) during SE and/or postictal period was the main factor that led to death. Coma was clearly aggravated by convulsions (3 of them died in uninterrupted SE) or depressive effect of AEDs with 9 patients (due to thiopental anesthesia in 6, Grand total 120 a Death was not the consequence of complications caused by the underlying disease. and multiple drugs in 3 patients). Grave complications, unexpected according to patients' previous health status occurred during coma with lethal outcome. They included bacterial pneumonia or sepsis among 9 of them, pneumothorax and pneumonia in case of 1, and pulmonary embolism in case of 1 patient.
Respiratory complications
Respiratory complications occurred in 55 (45.8%) patients who died: in 27 (22.5%) they were unrelated, and in 28 (23.4%) patients (14 with RD and 14 with apnea) they were temporarily related to antistatus therapy. In 47 (85.5%) patients RD or apnea occurred before and in 8 (14.5%) after the admission to ICU (in later group during the application of thiopental). Patients were resuscitated immediately and ventilated until breathing was restored. Only 39 (32.5%) needed prolonged artificial ventilation due to chronic RD caused by underlying disease, complications of coma or thiopental anesthesia. Although almost all patients were intubated in ER, none of patient was ventilated only because he/she was in SE, or before emergence of RD. In none of the patients death occurred directly due to RD or apnea but afterwards due to postanoxic complications.
Respiratory complications caused by therapy were provoked by most frequently used AEDs: diazepam, midazolam, and thiopental (eight patients each treated with AED), followed by chlormethiazole and phenobarbital (two patients each treated with AED), respectively. Overall, AEDs caused more than one respiratory complication with the most serious being apnea and cardiac arrest. No association of any particular AED and death outcome was found.
The most pronounced cases occurred in 3 out of 14 patients with no serious underlying disease who were admitted with no cardiac and respiratory function after intravenous injection of 10 mg of diazepam (1) or 15 mg of midazolam (2 patients). Before the admission, SE lasted 4, 1, and 2 h, respectively. All 3 patients were resuscitated immediately after admission in ER, ventilated and monitored in ICU, but died after 24-264 h in postanoxic coma.
Uninterrupted SE
With 12 patients (1.3%) SE did not stop until it caused death. Eight patients had initial and 4 intercurrent SE; 9 had GTC and 3 PM SE. Table 3 shows etiologies of uninterrupted SE. Although 2-6 (median: 4) ineffective AEDs were applied, SE continued for 13-936 h (median 184) before death. Two patients died due solely to serious underlying disease and with the remaining 10 patients due to combination of several etiologies.
In summary, convulsions contributed to death with 12 (10%), complications of therapy with 28 (23.3%) and complications caused by coma contributed to death with 27 (22.5%) patients (Table 1 ).
Discussion
Mortality among 13% of patients after the episode of SE is on lower end of the range, which goes from 9% to 22%. 4, 8, 9, 5, 10, 11 Probable reasons are lower incidence of initial SE (35% of our patients) and improved treatment and nursing. In an article from Switzerland mortality among patients with SE was even lower (7.6%), despite the larger percent (57%) of patients with initial SE. 12 The point is that in better health care systems mortality of SE may be at the lowest end of the range due to straightforward treatment of underlying disease and prevention of complications. 11, 12 In societies with suboptimal health care system and limited resources, the best prehospital and hospital organization and well trained physicians are not always available. This could be the cause for delayed or inadequate treatment of SE, underlying disease or complications and worse prognosis for patients with SE and should also be areas that require more attention.
In meta-analysis of 12 studies, 308 (18%) out of 1686 patients died.
2 In 89%, death was due to severe underlying disease, in 2% due to convulsions, and in remaining 9% due to ''other'' causes. In later group of patients (approximately 1 out of 10) there is no comment regarding the cause of death. The author criticized inevitable imprecision in attributing outcome to a particular group, making this distribution only an approximation. 2 In order to avoid this ambiguity we tried to analyze every fatality according to sequence of events and identified underlying disease, vigorous convulsions, antiepileptic therapy, and coma as independent detrimental factors. Underlying disease is the primary determinant of SE outcome as was recognized earlier. 9, 10, 13 In our study, severe underlying disease was the main etiology of death in 88% of patients. It appears that SE worsens natural progression of some underlying diseases. Mortality among patients with acute brain infarction and SE is three times higher than in patients with acute brain infarction and no SE.
14 This is important because acute brain infarction is the most common cause of SE among adults, especially among those older than 60 years. 15 Prognosis of other underlying diseases, such as purulent meningitis, or brain trauma, in the presence of SE is unfavorable too. 16 There is a study showing increased mortality among patients with PM compared with GTC SE, which was also demonstrated among our patients. Authors attribute increased mortality to higher frequency of destructive brain diseases (such as acute brain infarction) among patients with PM SE. 5 Mortality is increased even in patients with non-convulsive SE, where majority of patients had severe underlying disease. 17, 18 These findings emphasize dominant influence of severe underlying disease on outcome. The effects of convulsions and deranged homeostatic functions, less pronounced in PM or non-convulsive SE are less important. 19 There is an unresolved dilemma whether the risk of death in prolonged SE is increased compared to SE of shorter duration. 20, 21 In a group of 115 patients with favorable outcome, average duration of SE was 2.4 h, while in a group of 34 patients with unfavorable outcome (deaths and sequels) the duration was 11.2 h.
9 SE was significantly longer among patients with severe symptomatic underlying disease. This makes the confirmation of independent influence of prolonged duration of SE on mortality difficult. 22 Our results are in accord with findings of Knake et al. 15 suggesting a positive correlation between the duration of SE and mortality, with no critical duration after which mortality is increased. Some authors found no relation between duration and mortality and associated all deaths with the effects of underlying disease. 10, 7 Our point is that in prolonged SE complications occur more easily due to immobility, unconsciousness or altered cooperation. In addition, in prolonged SE, it is more probable that physician will decide to apply more AEDs in higher dose that may easily provoke serious respiratory complications. In our group, mortality unrelated to the effect of the underlying disease occurred in 14 patients. We ascribe those deaths to 25 At least in patients with GTC SE caused by severe underlying disease, severance of seizures induced by AEDs makes the treatment of underlying disease easier. 2 More importantly, SE therapy (especially of non-convulsive type) with elderly patients with severe underlying disease may increase mortality. 17, 24 It appears that SE among elderly patients should be treated more cautiously than in ''standard'' cases to avoid toxicity and complications associated with antistatus drugs. 24 It is intriguing that the AEDs complications are rarely reported. 2 Physicians are rarely aware of complications of benzodiazepines that may provoke apnea and RD in 3.7-24% of patients. 26, 23, 27, 28, 29 It was reported that one patient died exclusively due to the apnea caused by the application of 10 mg of diazepam. 23 Reports that pay heeds to complications or deaths due to other antistatus drugs are practically absent. 2 In our group, respiratory complications of therapy are the most probable reason of death in three, and in combination with other complications in additional 25 patients. However, severe underlying disease could arrange in advance to respiratory complication of AEDs, at least in some patients. 29 Although we found no obvious errors in recommended dosage or application rate of antistatus drugs, we think that with slower application rate, apnea or RD can be avoided in majority of patients. In a similar manner, better management can prevent the complications caused by convulsions and coma with enhanced outcome.
